カテゴリー： 世界, 医療/バイオ, Market Monitor Global

世界のトランスサイレチン安定剤市場予測2023-2029：ディフルニサル、タファミディス、その他

【英語タイトル】Transthyretin Stabilizer Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが出版した調査資料（MMG23LY8719）・商品コード：MMG23LY8719
・発行会社（調査会社）：Market Monitor Global
・発行日：2023年7月
・ページ数：79
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野：医薬品＆ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界のトランスサイレチン安定剤市場規模と予測を収録しています。・世界のトランスサイレチン安定剤市場：売上、2018年-2023年、2024年-2029年
・世界のトランスサイレチン安定剤市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のトランスサイレチン安定剤市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「ディフルニサル」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

トランスサイレチン安定剤のグローバル主要企業は、Pfizer Inc.、 Merck & Co.、 AstraZeneca Plc.、 GlaxoSmithKline Plc.、 Corino Therapeutics Inc.、 Alnylam Pharmaceuticals、 Bellus Health Inc.、 Ionis Pharmaceuticals, Inc.、 Proclara Bioscience、 Arturus Therapeutics、 Prothena Corporation Plc.などです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、トランスサイレチン安定剤のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のトランスサイレチン安定剤市場：タイプ別、2018年-2023年、2024年-2029年
世界のトランスサイレチン安定剤市場：タイプ別市場シェア、2022年
・ディフルニサル、タファミディス、その他

世界のトランスサイレチン安定剤市場：用途別、2018年-2023年、2024年-2029年
世界のトランスサイレチン安定剤市場：用途別市場シェア、2022年
・病院薬局、小売薬局、ドラッグストア、オンライン薬局、その他

世界のトランスサイレチン安定剤市場：地域・国別、2018年-2023年、2024年-2029年
世界のトランスサイレチン安定剤市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるトランスサイレチン安定剤のグローバル売上、2018年-2023年
・主要企業におけるトランスサイレチン安定剤のグローバル売上シェア、2022年
・主要企業におけるトランスサイレチン安定剤のグローバル販売量、2018年-2023年
・主要企業におけるトランスサイレチン安定剤のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Pfizer Inc.、 Merck & Co.、 AstraZeneca Plc.、 GlaxoSmithKline Plc.、 Corino Therapeutics Inc.、 Alnylam Pharmaceuticals、 Bellus Health Inc.、 Ionis Pharmaceuticals, Inc.、 Proclara Bioscience、 Arturus Therapeutics、 Prothena Corporation Plc.

*************************************************************

・調査・分析レポートの概要
トランスサイレチン安定剤市場の定義
市場セグメント
世界のトランスサイレチン安定剤市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のトランスサイレチン安定剤市場規模
世界のトランスサイレチン安定剤市場規模：2022年 VS 2029年
世界のトランスサイレチン安定剤市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのトランスサイレチン安定剤の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のトランスサイレチン安定剤製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：ディフルニサル、タファミディス、その他
トランスサイレチン安定剤のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院薬局、小売薬局、ドラッグストア、オンライン薬局、その他
トランスサイレチン安定剤の用途別グローバル売上・予測

・地域別市場分析
地域別トランスサイレチン安定剤市場規模 2022年と2029年
地域別トランスサイレチン安定剤売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Pfizer Inc.、 Merck & Co.、 AstraZeneca Plc.、 GlaxoSmithKline Plc.、 Corino Therapeutics Inc.、 Alnylam Pharmaceuticals、 Bellus Health Inc.、 Ionis Pharmaceuticals, Inc.、 Proclara Bioscience、 Arturus Therapeutics、 Prothena Corporation Plc.
...

Transthyretin found in serum and cerebrospinal fluid of body is one of the transport protein carrying thyroxine and retinol-binding proteins. Transthyretin destabilization can take place due to inherited mutations or ageing.Transthyretin stabilizers prevent destabilization of protein and amyloidosis progression.
This report aims to provide a comprehensive presentation of the global market for Transthyretin Stabilizer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transthyretin Stabilizer. This report contains market size and forecasts of Transthyretin Stabilizer in global, including the following market information:
Global Transthyretin Stabilizer Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Transthyretin Stabilizer Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Transthyretin Stabilizer companies in 2022 (%)
The global Transthyretin Stabilizer market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Diflunisal Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Transthyretin Stabilizer include Pfizer Inc., Merck & Co., AstraZeneca Plc., GlaxoSmithKline Plc., Corino Therapeutics Inc., Alnylam Pharmaceuticals, Bellus Health Inc., Ionis Pharmaceuticals, Inc. and Proclara Bioscience, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Transthyretin Stabilizer manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Transthyretin Stabilizer Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Transthyretin Stabilizer Market Segment Percentages, by Type, 2022 (%)
Diflunisal
Tafamidis
Others
Global Transthyretin Stabilizer Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Transthyretin Stabilizer Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Online Pharmacies
Others
Global Transthyretin Stabilizer Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Transthyretin Stabilizer Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Transthyretin Stabilizer revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Transthyretin Stabilizer revenues share in global market, 2022 (%)
Key companies Transthyretin Stabilizer sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Transthyretin Stabilizer sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer Inc.
Merck & Co.
AstraZeneca Plc.
GlaxoSmithKline Plc.
Corino Therapeutics Inc.
Alnylam Pharmaceuticals
Bellus Health Inc.
Ionis Pharmaceuticals, Inc.
Proclara Bioscience
Arturus Therapeutics
Prothena Corporation Plc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Transthyretin Stabilizer, market overview.
Chapter 2: Global Transthyretin Stabilizer market size in revenue and volume.
Chapter 3: Detailed analysis of Transthyretin Stabilizer manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Transthyretin Stabilizer in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Transthyretin Stabilizer capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Transthyretin Stabilizer Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Transthyretin Stabilizer Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Transthyretin Stabilizer Overall Market Size
2.1 Global Transthyretin Stabilizer Market Size: 2022 VS 2029
2.2 Global Transthyretin Stabilizer Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Transthyretin Stabilizer Sales: 2018-2029
3 Company Landscape
3.1 Top Transthyretin Stabilizer Players in Global Market
3.2 Top Global Transthyretin Stabilizer Companies Ranked by Revenue
3.3 Global Transthyretin Stabilizer Revenue by Companies
3.4 Global Transthyretin Stabilizer Sales by Companies
3.5 Global Transthyretin Stabilizer Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Transthyretin Stabilizer Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Transthyretin Stabilizer Product Type
3.8 Tier 1, Tier 2 and Tier 3 Transthyretin Stabilizer Players in Global Market
3.8.1 List of Global Tier 1 Transthyretin Stabilizer Companies
3.8.2 List of Global Tier 2 and Tier 3 Transthyretin Stabilizer Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Transthyretin Stabilizer Market Size Markets, 2022 & 2029
4.1.2 Diflunisal
4.1.3 Tafamidis
4.1.4 Others
4.2 By Type – Global Transthyretin Stabilizer Revenue & Forecasts
4.2.1 By Type – Global Transthyretin Stabilizer Revenue, 2018-2023
4.2.2 By Type – Global Transthyretin Stabilizer Revenue, 2024-2029
4.2.3 By Type – Global Transthyretin Stabilizer Revenue Market Share, 2018-2029
4.3 By Type – Global Transthyretin Stabilizer Sales & Forecasts
4.3.1 By Type – Global Transthyretin Stabilizer Sales, 2018-2023
4.3.2 By Type – Global Transthyretin Stabilizer Sales, 2024-2029
4.3.3 By Type – Global Transthyretin Stabilizer Sales Market Share, 2018-2029
4.4 By Type – Global Transthyretin Stabilizer Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Transthyretin Stabilizer Market Size, 2022 & 2029
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Drug Stores
5.1.5 Online Pharmacies
5.1.6 Others
5.2 By Application – Global Transthyretin Stabilizer Revenue & Forecasts
5.2.1 By Application – Global Transthyretin Stabilizer Revenue, 2018-2023
5.2.2 By Application – Global Transthyretin Stabilizer Revenue, 2024-2029
5.2.3 By Application – Global Transthyretin Stabilizer Revenue Market Share, 2018-2029
5.3 By Application – Global Transthyretin Stabilizer Sales & Forecasts
5.3.1 By Application – Global Transthyretin Stabilizer Sales, 2018-2023
5.3.2 By Application – Global Transthyretin Stabilizer Sales, 2024-2029
5.3.3 By Application – Global Transthyretin Stabilizer Sales Market Share, 2018-2029
5.4 By Application – Global Transthyretin Stabilizer Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Transthyretin Stabilizer Market Size, 2022 & 2029
6.2 By Region – Global Transthyretin Stabilizer Revenue & Forecasts
6.2.1 By Region – Global Transthyretin Stabilizer Revenue, 2018-2023
6.2.2 By Region – Global Transthyretin Stabilizer Revenue, 2024-2029
6.2.3 By Region – Global Transthyretin Stabilizer Revenue Market Share, 2018-2029
6.3 By Region – Global Transthyretin Stabilizer Sales & Forecasts
6.3.1 By Region – Global Transthyretin Stabilizer Sales, 2018-2023
6.3.2 By Region – Global Transthyretin Stabilizer Sales, 2024-2029
6.3.3 By Region – Global Transthyretin Stabilizer Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Transthyretin Stabilizer Revenue, 2018-2029
6.4.2 By Country – North America Transthyretin Stabilizer Sales, 2018-2029
6.4.3 US Transthyretin Stabilizer Market Size, 2018-2029
6.4.4 Canada Transthyretin Stabilizer Market Size, 2018-2029
6.4.5 Mexico Transthyretin Stabilizer Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Transthyretin Stabilizer Revenue, 2018-2029
6.5.2 By Country – Europe Transthyretin Stabilizer Sales, 2018-2029
6.5.3 Germany Transthyretin Stabilizer Market Size, 2018-2029
6.5.4 France Transthyretin Stabilizer Market Size, 2018-2029
6.5.5 U.K. Transthyretin Stabilizer Market Size, 2018-2029
6.5.6 Italy Transthyretin Stabilizer Market Size, 2018-2029
6.5.7 Russia Transthyretin Stabilizer Market Size, 2018-2029
6.5.8 Nordic Countries Transthyretin Stabilizer Market Size, 2018-2029
6.5.9 Benelux Transthyretin Stabilizer Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Transthyretin Stabilizer Revenue, 2018-2029
6.6.2 By Region – Asia Transthyretin Stabilizer Sales, 2018-2029
6.6.3 China Transthyretin Stabilizer Market Size, 2018-2029
6.6.4 Japan Transthyretin Stabilizer Market Size, 2018-2029
6.6.5 South Korea Transthyretin Stabilizer Market Size, 2018-2029
6.6.6 Southeast Asia Transthyretin Stabilizer Market Size, 2018-2029
6.6.7 India Transthyretin Stabilizer Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Transthyretin Stabilizer Revenue, 2018-2029
6.7.2 By Country – South America Transthyretin Stabilizer Sales, 2018-2029
6.7.3 Brazil Transthyretin Stabilizer Market Size, 2018-2029
6.7.4 Argentina Transthyretin Stabilizer Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Transthyretin Stabilizer Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Transthyretin Stabilizer Sales, 2018-2029
6.8.3 Turkey Transthyretin Stabilizer Market Size, 2018-2029
6.8.4 Israel Transthyretin Stabilizer Market Size, 2018-2029
6.8.5 Saudi Arabia Transthyretin Stabilizer Market Size, 2018-2029
6.8.6 UAE Transthyretin Stabilizer Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Pfizer Inc.
7.1.1 Pfizer Inc. Company Summary
7.1.2 Pfizer Inc. Business Overview
7.1.3 Pfizer Inc. Transthyretin Stabilizer Major Product Offerings
7.1.4 Pfizer Inc. Transthyretin Stabilizer Sales and Revenue in Global (2018-2023)
7.1.5 Pfizer Inc. Key News & Latest Developments
7.2 Merck & Co.
7.2.1 Merck & Co. Company Summary
7.2.2 Merck & Co. Business Overview
7.2.3 Merck & Co. Transthyretin Stabilizer Major Product Offerings
7.2.4 Merck & Co. Transthyretin Stabilizer Sales and Revenue in Global (2018-2023)
7.2.5 Merck & Co. Key News & Latest Developments
7.3 AstraZeneca Plc.
7.3.1 AstraZeneca Plc. Company Summary
7.3.2 AstraZeneca Plc. Business Overview
7.3.3 AstraZeneca Plc. Transthyretin Stabilizer Major Product Offerings
7.3.4 AstraZeneca Plc. Transthyretin Stabilizer Sales and Revenue in Global (2018-2023)
7.3.5 AstraZeneca Plc. Key News & Latest Developments
7.4 GlaxoSmithKline Plc.
7.4.1 GlaxoSmithKline Plc. Company Summary
7.4.2 GlaxoSmithKline Plc. Business Overview
7.4.3 GlaxoSmithKline Plc. Transthyretin Stabilizer Major Product Offerings
7.4.4 GlaxoSmithKline Plc. Transthyretin Stabilizer Sales and Revenue in Global (2018-2023)
7.4.5 GlaxoSmithKline Plc. Key News & Latest Developments
7.5 Corino Therapeutics Inc.
7.5.1 Corino Therapeutics Inc. Company Summary
7.5.2 Corino Therapeutics Inc. Business Overview
7.5.3 Corino Therapeutics Inc. Transthyretin Stabilizer Major Product Offerings
7.5.4 Corino Therapeutics Inc. Transthyretin Stabilizer Sales and Revenue in Global (2018-2023)
7.5.5 Corino Therapeutics Inc. Key News & Latest Developments
7.6 Alnylam Pharmaceuticals
7.6.1 Alnylam Pharmaceuticals Company Summary
7.6.2 Alnylam Pharmaceuticals Business Overview
7.6.3 Alnylam Pharmaceuticals Transthyretin Stabilizer Major Product Offerings
7.6.4 Alnylam Pharmaceuticals Transthyretin Stabilizer Sales and Revenue in Global (2018-2023)
7.6.5 Alnylam Pharmaceuticals Key News & Latest Developments
7.7 Bellus Health Inc.
7.7.1 Bellus Health Inc. Company Summary
7.7.2 Bellus Health Inc. Business Overview
7.7.3 Bellus Health Inc. Transthyretin Stabilizer Major Product Offerings
7.7.4 Bellus Health Inc. Transthyretin Stabilizer Sales and Revenue in Global (2018-2023)
7.7.5 Bellus Health Inc. Key News & Latest Developments
7.8 Ionis Pharmaceuticals, Inc.
7.8.1 Ionis Pharmaceuticals, Inc. Company Summary
7.8.2 Ionis Pharmaceuticals, Inc. Business Overview
7.8.3 Ionis Pharmaceuticals, Inc. Transthyretin Stabilizer Major Product Offerings
7.8.4 Ionis Pharmaceuticals, Inc. Transthyretin Stabilizer Sales and Revenue in Global (2018-2023)
7.8.5 Ionis Pharmaceuticals, Inc. Key News & Latest Developments
7.9 Proclara Bioscience
7.9.1 Proclara Bioscience Company Summary
7.9.2 Proclara Bioscience Business Overview
7.9.3 Proclara Bioscience Transthyretin Stabilizer Major Product Offerings
7.9.4 Proclara Bioscience Transthyretin Stabilizer Sales and Revenue in Global (2018-2023)
7.9.5 Proclara Bioscience Key News & Latest Developments
7.10 Arturus Therapeutics
7.10.1 Arturus Therapeutics Company Summary
7.10.2 Arturus Therapeutics Business Overview
7.10.3 Arturus Therapeutics Transthyretin Stabilizer Major Product Offerings
7.10.4 Arturus Therapeutics Transthyretin Stabilizer Sales and Revenue in Global (2018-2023)
7.10.5 Arturus Therapeutics Key News & Latest Developments
7.11 Prothena Corporation Plc.
7.11.1 Prothena Corporation Plc. Company Summary
7.11.2 Prothena Corporation Plc. Transthyretin Stabilizer Business Overview
7.11.3 Prothena Corporation Plc. Transthyretin Stabilizer Major Product Offerings
7.11.4 Prothena Corporation Plc. Transthyretin Stabilizer Sales and Revenue in Global (2018-2023)
7.11.5 Prothena Corporation Plc. Key News & Latest Developments
8 Global Transthyretin Stabilizer Production Capacity, Analysis
8.1 Global Transthyretin Stabilizer Production Capacity, 2018-2029
8.2 Transthyretin Stabilizer Production Capacity of Key Manufacturers in Global Market
8.3 Global Transthyretin Stabilizer Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Transthyretin Stabilizer Supply Chain Analysis
10.1 Transthyretin Stabilizer Industry Value Chain
10.2 Transthyretin Stabilizer Upstream Market
10.3 Transthyretin Stabilizer Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Transthyretin Stabilizer Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Transthyretin Stabilizer in Global Market
Table 2. Top Transthyretin Stabilizer Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Transthyretin Stabilizer Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Transthyretin Stabilizer Revenue Share by Companies, 2018-2023
Table 5. Global Transthyretin Stabilizer Sales by Companies, (K Units), 2018-2023
Table 6. Global Transthyretin Stabilizer Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Transthyretin Stabilizer Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Transthyretin Stabilizer Product Type
Table 9. List of Global Tier 1 Transthyretin Stabilizer Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Transthyretin Stabilizer Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Transthyretin Stabilizer Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Transthyretin Stabilizer Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Transthyretin Stabilizer Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Transthyretin Stabilizer Sales (K Units), 2018-2023
Table 15. By Type - Global Transthyretin Stabilizer Sales (K Units), 2024-2029
Table 16. By Application – Global Transthyretin Stabilizer Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Transthyretin Stabilizer Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Transthyretin Stabilizer Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Transthyretin Stabilizer Sales (K Units), 2018-2023
Table 20. By Application - Global Transthyretin Stabilizer Sales (K Units), 2024-2029
Table 21. By Region – Global Transthyretin Stabilizer Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Transthyretin Stabilizer Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Transthyretin Stabilizer Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Transthyretin Stabilizer Sales (K Units), 2018-2023
Table 25. By Region - Global Transthyretin Stabilizer Sales (K Units), 2024-2029
Table 26. By Country - North America Transthyretin Stabilizer Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Transthyretin Stabilizer Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Transthyretin Stabilizer Sales, (K Units), 2018-2023
Table 29. By Country - North America Transthyretin Stabilizer Sales, (K Units), 2024-2029
Table 30. By Country - Europe Transthyretin Stabilizer Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Transthyretin Stabilizer Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Transthyretin Stabilizer Sales, (K Units), 2018-2023
Table 33. By Country - Europe Transthyretin Stabilizer Sales, (K Units), 2024-2029
Table 34. By Region - Asia Transthyretin Stabilizer Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Transthyretin Stabilizer Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Transthyretin Stabilizer Sales, (K Units), 2018-2023
Table 37. By Region - Asia Transthyretin Stabilizer Sales, (K Units), 2024-2029
Table 38. By Country - South America Transthyretin Stabilizer Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Transthyretin Stabilizer Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Transthyretin Stabilizer Sales, (K Units), 2018-2023
Table 41. By Country - South America Transthyretin Stabilizer Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Transthyretin Stabilizer Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Transthyretin Stabilizer Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Transthyretin Stabilizer Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Transthyretin Stabilizer Sales, (K Units), 2024-2029
Table 46. Pfizer Inc. Company Summary
Table 47. Pfizer Inc. Transthyretin Stabilizer Product Offerings
Table 48. Pfizer Inc. Transthyretin Stabilizer Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Pfizer Inc. Key News & Latest Developments
Table 50. Merck & Co. Company Summary
Table 51. Merck & Co. Transthyretin Stabilizer Product Offerings
Table 52. Merck & Co. Transthyretin Stabilizer Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Merck & Co. Key News & Latest Developments
Table 54. AstraZeneca Plc. Company Summary
Table 55. AstraZeneca Plc. Transthyretin Stabilizer Product Offerings
Table 56. AstraZeneca Plc. Transthyretin Stabilizer Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. AstraZeneca Plc. Key News & Latest Developments
Table 58. GlaxoSmithKline Plc. Company Summary
Table 59. GlaxoSmithKline Plc. Transthyretin Stabilizer Product Offerings
Table 60. GlaxoSmithKline Plc. Transthyretin Stabilizer Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. GlaxoSmithKline Plc. Key News & Latest Developments
Table 62. Corino Therapeutics Inc. Company Summary
Table 63. Corino Therapeutics Inc. Transthyretin Stabilizer Product Offerings
Table 64. Corino Therapeutics Inc. Transthyretin Stabilizer Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Corino Therapeutics Inc. Key News & Latest Developments
Table 66. Alnylam Pharmaceuticals Company Summary
Table 67. Alnylam Pharmaceuticals Transthyretin Stabilizer Product Offerings
Table 68. Alnylam Pharmaceuticals Transthyretin Stabilizer Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Alnylam Pharmaceuticals Key News & Latest Developments
Table 70. Bellus Health Inc. Company Summary
Table 71. Bellus Health Inc. Transthyretin Stabilizer Product Offerings
Table 72. Bellus Health Inc. Transthyretin Stabilizer Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Bellus Health Inc. Key News & Latest Developments
Table 74. Ionis Pharmaceuticals, Inc. Company Summary
Table 75. Ionis Pharmaceuticals, Inc. Transthyretin Stabilizer Product Offerings
Table 76. Ionis Pharmaceuticals, Inc. Transthyretin Stabilizer Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Ionis Pharmaceuticals, Inc. Key News & Latest Developments
Table 78. Proclara Bioscience Company Summary
Table 79. Proclara Bioscience Transthyretin Stabilizer Product Offerings
Table 80. Proclara Bioscience Transthyretin Stabilizer Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Proclara Bioscience Key News & Latest Developments
Table 82. Arturus Therapeutics Company Summary
Table 83. Arturus Therapeutics Transthyretin Stabilizer Product Offerings
Table 84. Arturus Therapeutics Transthyretin Stabilizer Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Arturus Therapeutics Key News & Latest Developments
Table 86. Prothena Corporation Plc. Company Summary
Table 87. Prothena Corporation Plc. Transthyretin Stabilizer Product Offerings
Table 88. Prothena Corporation Plc. Transthyretin Stabilizer Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. Prothena Corporation Plc. Key News & Latest Developments
Table 90. Transthyretin Stabilizer Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 91. Global Transthyretin Stabilizer Capacity Market Share of Key Manufacturers, 2021-2023
Table 92. Global Transthyretin Stabilizer Production by Region, 2018-2023 (K Units)
Table 93. Global Transthyretin Stabilizer Production by Region, 2024-2029 (K Units)
Table 94. Transthyretin Stabilizer Market Opportunities & Trends in Global Market
Table 95. Transthyretin Stabilizer Market Drivers in Global Market
Table 96. Transthyretin Stabilizer Market Restraints in Global Market
Table 97. Transthyretin Stabilizer Raw Materials
Table 98. Transthyretin Stabilizer Raw Materials Suppliers in Global Market
Table 99. Typical Transthyretin Stabilizer Downstream
Table 100. Transthyretin Stabilizer Downstream Clients in Global Market
Table 101. Transthyretin Stabilizer Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Transthyretin Stabilizer Segment by Type in 2022
Figure 2. Transthyretin Stabilizer Segment by Application in 2022
Figure 3. Global Transthyretin Stabilizer Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Transthyretin Stabilizer Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Transthyretin Stabilizer Revenue, 2018-2029 (US$, Mn)
Figure 7. Transthyretin Stabilizer Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Transthyretin Stabilizer Revenue in 2022
Figure 9. By Type - Global Transthyretin Stabilizer Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Transthyretin Stabilizer Revenue Market Share, 2018-2029
Figure 11. By Type - Global Transthyretin Stabilizer Sales Market Share, 2018-2029
Figure 12. By Type - Global Transthyretin Stabilizer Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Transthyretin Stabilizer Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Transthyretin Stabilizer Revenue Market Share, 2018-2029
Figure 15. By Application - Global Transthyretin Stabilizer Sales Market Share, 2018-2029
Figure 16. By Application - Global Transthyretin Stabilizer Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Transthyretin Stabilizer Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Transthyretin Stabilizer Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Transthyretin Stabilizer Revenue Market Share, 2018-2029
Figure 20. By Region - Global Transthyretin Stabilizer Sales Market Share, 2018-2029
Figure 21. By Country - North America Transthyretin Stabilizer Revenue Market Share, 2018-2029
Figure 22. By Country - North America Transthyretin Stabilizer Sales Market Share, 2018-2029
Figure 23. US Transthyretin Stabilizer Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Transthyretin Stabilizer Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Transthyretin Stabilizer Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Transthyretin Stabilizer Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Transthyretin Stabilizer Sales Market Share, 2018-2029
Figure 28. Germany Transthyretin Stabilizer Revenue, (US$, Mn), 2018-2029
Figure 29. France Transthyretin Stabilizer Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Transthyretin Stabilizer Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Transthyretin Stabilizer Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Transthyretin Stabilizer Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Transthyretin Stabilizer Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Transthyretin Stabilizer Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Transthyretin Stabilizer Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Transthyretin Stabilizer Sales Market Share, 2018-2029
Figure 37. China Transthyretin Stabilizer Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Transthyretin Stabilizer Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Transthyretin Stabilizer Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Transthyretin Stabilizer Revenue, (US$, Mn), 2018-2029
Figure 41. India Transthyretin Stabilizer Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Transthyretin Stabilizer Revenue Market Share, 2018-2029
Figure 43. By Country - South America Transthyretin Stabilizer Sales Market Share, 2018-2029
Figure 44. Brazil Transthyretin Stabilizer Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Transthyretin Stabilizer Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Transthyretin Stabilizer Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Transthyretin Stabilizer Sales Market Share, 2018-2029
Figure 48. Turkey Transthyretin Stabilizer Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Transthyretin Stabilizer Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Transthyretin Stabilizer Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Transthyretin Stabilizer Revenue, (US$, Mn), 2018-2029
Figure 52. Global Transthyretin Stabilizer Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Transthyretin Stabilizer by Region, 2022 VS 2029
Figure 54. Transthyretin Stabilizer Industry Value Chain
Figure 55. Marketing Channels


★調査レポート[世界のトランスサイレチン安定剤市場予測2023-2029：ディフルニサル、タファミディス、その他] (コード：MMG23LY8719)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のトランスサイレチン安定剤市場予測2023-2029：ディフルニサル、タファミディス、その他]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • タファミディス・メグルミンの世界市場インサイト・予測（～2028年）
  • 世界のタンパク質及びペプチド治療薬市場予測2023-2029：注射式、経口式
  • 世界のベクターベースRNAi市場予測2023-2029：siRNA設計、siRNAベクター、カスタムsiRNA構築
  • 世界の腎代替療法市場予測2023-2029：デバイス、消耗品、サービス
  • 世界の腫瘍免疫療法市場予測2023-2029：モノクローナル抗体、免疫チェックポイント阻害剤、免疫系調節剤、がんワクチン

    • ◆H&Iグローバルリサーチのお客様（例）◆